Company profile for Numinus

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Numinus (TSXV:NUMI) is a healthcare company at the forefront of addressing the growing prevalence of mental health issues and desire for greater wellness. The company offers an integrated therapeutic model to create lifelong relationships with people seeking physical, mental and emotional health with a focus on treating mental illness, trauma and substance abuse. In addition to services including counselling, neurofeedback, p...
Numinus (TSXV:NUMI) is a healthcare company at the forefront of addressing the growing prevalence of mental health issues and desire for greater wellness. The company offers an integrated therapeutic model to create lifelong relationships with people seeking physical, mental and emotional health with a focus on treating mental illness, trauma and substance abuse. In addition to services including counselling, neurofeedback, physiotherapy and other therapies, Numinus aims to conduct psychedelic-assisted therapies to help people heal, connect and grow — when approved by Health Canada, Colleges and other regulators.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
250-997 Seymour Street, Suite 801, Vancouver, BC V6B 3M1
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

34th NZW-Hamburg

Not Confirmed

envelop Contact Supplier

34th NZW-Hamburg

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/06/20/2901549/0/en/MedBright-AI-Announces-Strategic-Acquisition-by-Numinus-Wellness.html

GLOBENEWSWIRE
20 Jun 2024
Canadian company hopes to take psychedelic therapy mainstream
Canadian company hopes to take psychedelic therapy mainstream

24 Jan 2023

// Sharon Klahr Coey FIERCE PHARMA

https://www.fiercepharma.com/marketing/canadian-company-hopes-take-psychedelic-therapy-mainstream

Sharon Klahr Coey FIERCE PHARMA
24 Jan 2023

https://www.accesswire.com/704051/Novamind-Shareholders-Approve-Proposed-Acquisition-by-Numinus

ACCESSWIRE
08 Jun 2022
Numinus to Acquire Novamind
Numinus to Acquire Novamind

12 Apr 2022

// ACCESSWIRE

https://www.accesswire.com/696918/Numinus-to-Acquire-Novamind-Creating-the-North-American-Industry-Leader-in-Psychedelic-Therapy-and-Research

ACCESSWIRE
12 Apr 2022

https://www.clinicaltrialsarena.com/news/numinus-canada-psychedelic-product/

CLINICALTRIALSARENA
17 Jan 2022

https://www.prnewswire.com/news-releases/numinus-to-host-extension-of-maps-sponsored-mdma-assisted-therapy-for-ptsd-trials-301420678.html

PRNEWSWIRE
10 Nov 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty